Medical Care
Global Circulating Tumor Cells (CTC) Market Research Report 2025
- Jul 29, 25
- ID: 409783
- Pages: 99
- Figures: 99
- Views: 18
The global market for Circulating Tumor Cells (CTC) was valued at US$ 1729 million in the year 2024 and is projected to reach a revised size of US$ 4279 million by 2031, growing at a CAGR of 14.6% during the forecast period.
Circulating tumor cells (CTC) refer to malignant tumor cells that fall off from primary tumors or metastatic foci and enter the peripheral blood circulation. They are the root cause of tumor recurrence and metastasis, the "seeds" of cancer metastasis, and can spread to distant organs through the blood to form metastatic foci. They are rare, atypical, heterogeneous, and diverse, and are used in early clinical diagnosis, prognosis evaluation, and efficacy monitoring. The clinical application of CTC is mainly concentrated in prognosis judgment, clinical tumor staging, disease monitoring, and efficacy evaluation. In addition, it has a wide range of applications in tumor screening and monitoring, tumor drug/therapy research and development, tumor pathology research, EMT biomarker research, and cancer stem cell research.
At present, the rising incidence of cancer, the demand for early screening, personalized treatment, technology progress and government policy support (such as AJCC, NCCN, and China CSCO guidelines) are all driving the continuous development of the circulating tumor cell (CTC) market. The North American market is technologically advanced, and strict regulation in the European market promotes standardization, with Germany and the United Kingdom leading research and development. Asia-Pacific China is growing rapidly, and the government has introduced policy support (such as "Healthy China 2030"). Demand in India and Southeast Asia is growing, cost-sensitive testing is popular, and localized production in China, India and other countries reduces costs. In the future, technology will develop in the direction of multi-omics integration, AI-assisted analysis, intelligent upgrades, and portability. Of course, it also faces challenges such as technical bottlenecks, high costs, lack of standards, and risks of false negatives.
This report aims to provide a comprehensive presentation of the global market for Circulating Tumor Cells (CTC), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Circulating Tumor Cells (CTC).
The Circulating Tumor Cells (CTC) market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Circulating Tumor Cells (CTC) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Circulating Tumor Cells (CTC) companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Qiagen
Bio-Rad
Johnson & Johnson
Thermo Fisher Scientific
Ikonisys
Miltenyi Biotech
Rarecells
Vitatex
Menarini Silicon Biosystems
Bio-Techne
BioFluidica
Gilupi
BioView
ScreenCell
Wuhan YZY Medical Science & Technology
NanoLite Systems
Watson Biotech
DunWill
Guangzhou Wondfo Biotech
Segment by Type
Testing Equipment and Instruments
Kits and Reagents
Blood Collection Tubes
Others
Segment by Application
Clinical Diagnosis and Treatment
Screening and Monitoring
Drug/Therapy Development
Tumor Pathology Research
Emt Biomarker Research
Cancer Stem Cell Research
Others
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Circulating Tumor Cells (CTC) company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Circulating tumor cells (CTC) refer to malignant tumor cells that fall off from primary tumors or metastatic foci and enter the peripheral blood circulation. They are the root cause of tumor recurrence and metastasis, the "seeds" of cancer metastasis, and can spread to distant organs through the blood to form metastatic foci. They are rare, atypical, heterogeneous, and diverse, and are used in early clinical diagnosis, prognosis evaluation, and efficacy monitoring. The clinical application of CTC is mainly concentrated in prognosis judgment, clinical tumor staging, disease monitoring, and efficacy evaluation. In addition, it has a wide range of applications in tumor screening and monitoring, tumor drug/therapy research and development, tumor pathology research, EMT biomarker research, and cancer stem cell research.
At present, the rising incidence of cancer, the demand for early screening, personalized treatment, technology progress and government policy support (such as AJCC, NCCN, and China CSCO guidelines) are all driving the continuous development of the circulating tumor cell (CTC) market. The North American market is technologically advanced, and strict regulation in the European market promotes standardization, with Germany and the United Kingdom leading research and development. Asia-Pacific China is growing rapidly, and the government has introduced policy support (such as "Healthy China 2030"). Demand in India and Southeast Asia is growing, cost-sensitive testing is popular, and localized production in China, India and other countries reduces costs. In the future, technology will develop in the direction of multi-omics integration, AI-assisted analysis, intelligent upgrades, and portability. Of course, it also faces challenges such as technical bottlenecks, high costs, lack of standards, and risks of false negatives.
This report aims to provide a comprehensive presentation of the global market for Circulating Tumor Cells (CTC), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Circulating Tumor Cells (CTC).
The Circulating Tumor Cells (CTC) market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Circulating Tumor Cells (CTC) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Circulating Tumor Cells (CTC) companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Qiagen
Bio-Rad
Johnson & Johnson
Thermo Fisher Scientific
Ikonisys
Miltenyi Biotech
Rarecells
Vitatex
Menarini Silicon Biosystems
Bio-Techne
BioFluidica
Gilupi
BioView
ScreenCell
Wuhan YZY Medical Science & Technology
NanoLite Systems
Watson Biotech
DunWill
Guangzhou Wondfo Biotech
Segment by Type
Testing Equipment and Instruments
Kits and Reagents
Blood Collection Tubes
Others
Segment by Application
Clinical Diagnosis and Treatment
Screening and Monitoring
Drug/Therapy Development
Tumor Pathology Research
Emt Biomarker Research
Cancer Stem Cell Research
Others
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Circulating Tumor Cells (CTC) company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Circulating Tumor Cells (CTC) Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Testing Equipment and Instruments
1.2.3 Kits and Reagents
1.2.4 Blood Collection Tubes
1.2.5 Others
1.3 Market by Application
1.3.1 Global Circulating Tumor Cells (CTC) Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Clinical Diagnosis and Treatment
1.3.3 Screening and Monitoring
1.3.4 Drug/Therapy Development
1.3.5 Tumor Pathology Research
1.3.6 Emt Biomarker Research
1.3.7 Cancer Stem Cell Research
1.3.8 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Circulating Tumor Cells (CTC) Market Perspective (2020-2031)
2.2 Global Circulating Tumor Cells (CTC) Growth Trends by Region
2.2.1 Global Circulating Tumor Cells (CTC) Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Circulating Tumor Cells (CTC) Historic Market Size by Region (2020-2025)
2.2.3 Circulating Tumor Cells (CTC) Forecasted Market Size by Region (2026-2031)
2.3 Circulating Tumor Cells (CTC) Market Dynamics
2.3.1 Circulating Tumor Cells (CTC) Industry Trends
2.3.2 Circulating Tumor Cells (CTC) Market Drivers
2.3.3 Circulating Tumor Cells (CTC) Market Challenges
2.3.4 Circulating Tumor Cells (CTC) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Circulating Tumor Cells (CTC) Players by Revenue
3.1.1 Global Top Circulating Tumor Cells (CTC) Players by Revenue (2020-2025)
3.1.2 Global Circulating Tumor Cells (CTC) Revenue Market Share by Players (2020-2025)
3.2 Global Top Circulating Tumor Cells (CTC) Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Circulating Tumor Cells (CTC) Revenue
3.4 Global Circulating Tumor Cells (CTC) Market Concentration Ratio
3.4.1 Global Circulating Tumor Cells (CTC) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Circulating Tumor Cells (CTC) Revenue in 2024
3.5 Global Key Players of Circulating Tumor Cells (CTC) Head office and Area Served
3.6 Global Key Players of Circulating Tumor Cells (CTC), Product and Application
3.7 Global Key Players of Circulating Tumor Cells (CTC), Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Circulating Tumor Cells (CTC) Breakdown Data by Type
4.1 Global Circulating Tumor Cells (CTC) Historic Market Size by Type (2020-2025)
4.2 Global Circulating Tumor Cells (CTC) Forecasted Market Size by Type (2026-2031)
5 Circulating Tumor Cells (CTC) Breakdown Data by Application
5.1 Global Circulating Tumor Cells (CTC) Historic Market Size by Application (2020-2025)
5.2 Global Circulating Tumor Cells (CTC) Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Circulating Tumor Cells (CTC) Market Size (2020-2031)
6.2 North America Circulating Tumor Cells (CTC) Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Circulating Tumor Cells (CTC) Market Size by Country (2020-2025)
6.4 North America Circulating Tumor Cells (CTC) Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Circulating Tumor Cells (CTC) Market Size (2020-2031)
7.2 Europe Circulating Tumor Cells (CTC) Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Circulating Tumor Cells (CTC) Market Size by Country (2020-2025)
7.4 Europe Circulating Tumor Cells (CTC) Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Circulating Tumor Cells (CTC) Market Size (2020-2031)
8.2 Asia-Pacific Circulating Tumor Cells (CTC) Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Circulating Tumor Cells (CTC) Market Size by Region (2020-2025)
8.4 Asia-Pacific Circulating Tumor Cells (CTC) Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Circulating Tumor Cells (CTC) Market Size (2020-2031)
9.2 Latin America Circulating Tumor Cells (CTC) Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Circulating Tumor Cells (CTC) Market Size by Country (2020-2025)
9.4 Latin America Circulating Tumor Cells (CTC) Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Circulating Tumor Cells (CTC) Market Size (2020-2031)
10.2 Middle East & Africa Circulating Tumor Cells (CTC) Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Circulating Tumor Cells (CTC) Market Size by Country (2020-2025)
10.4 Middle East & Africa Circulating Tumor Cells (CTC) Market Size by Country (2026-2031)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Qiagen
11.1.1 Qiagen Company Details
11.1.2 Qiagen Business Overview
11.1.3 Qiagen Circulating Tumor Cells (CTC) Introduction
11.1.4 Qiagen Revenue in Circulating Tumor Cells (CTC) Business (2020-2025)
11.1.5 Qiagen Recent Development
11.2 Bio-Rad
11.2.1 Bio-Rad Company Details
11.2.2 Bio-Rad Business Overview
11.2.3 Bio-Rad Circulating Tumor Cells (CTC) Introduction
11.2.4 Bio-Rad Revenue in Circulating Tumor Cells (CTC) Business (2020-2025)
11.2.5 Bio-Rad Recent Development
11.3 Johnson & Johnson
11.3.1 Johnson & Johnson Company Details
11.3.2 Johnson & Johnson Business Overview
11.3.3 Johnson & Johnson Circulating Tumor Cells (CTC) Introduction
11.3.4 Johnson & Johnson Revenue in Circulating Tumor Cells (CTC) Business (2020-2025)
11.3.5 Johnson & Johnson Recent Development
11.4 Thermo Fisher Scientific
11.4.1 Thermo Fisher Scientific Company Details
11.4.2 Thermo Fisher Scientific Business Overview
11.4.3 Thermo Fisher Scientific Circulating Tumor Cells (CTC) Introduction
11.4.4 Thermo Fisher Scientific Revenue in Circulating Tumor Cells (CTC) Business (2020-2025)
11.4.5 Thermo Fisher Scientific Recent Development
11.5 Ikonisys
11.5.1 Ikonisys Company Details
11.5.2 Ikonisys Business Overview
11.5.3 Ikonisys Circulating Tumor Cells (CTC) Introduction
11.5.4 Ikonisys Revenue in Circulating Tumor Cells (CTC) Business (2020-2025)
11.5.5 Ikonisys Recent Development
11.6 Miltenyi Biotech
11.6.1 Miltenyi Biotech Company Details
11.6.2 Miltenyi Biotech Business Overview
11.6.3 Miltenyi Biotech Circulating Tumor Cells (CTC) Introduction
11.6.4 Miltenyi Biotech Revenue in Circulating Tumor Cells (CTC) Business (2020-2025)
11.6.5 Miltenyi Biotech Recent Development
11.7 Rarecells
11.7.1 Rarecells Company Details
11.7.2 Rarecells Business Overview
11.7.3 Rarecells Circulating Tumor Cells (CTC) Introduction
11.7.4 Rarecells Revenue in Circulating Tumor Cells (CTC) Business (2020-2025)
11.7.5 Rarecells Recent Development
11.8 Vitatex
11.8.1 Vitatex Company Details
11.8.2 Vitatex Business Overview
11.8.3 Vitatex Circulating Tumor Cells (CTC) Introduction
11.8.4 Vitatex Revenue in Circulating Tumor Cells (CTC) Business (2020-2025)
11.8.5 Vitatex Recent Development
11.9 Menarini Silicon Biosystems
11.9.1 Menarini Silicon Biosystems Company Details
11.9.2 Menarini Silicon Biosystems Business Overview
11.9.3 Menarini Silicon Biosystems Circulating Tumor Cells (CTC) Introduction
11.9.4 Menarini Silicon Biosystems Revenue in Circulating Tumor Cells (CTC) Business (2020-2025)
11.9.5 Menarini Silicon Biosystems Recent Development
11.10 Bio-Techne
11.10.1 Bio-Techne Company Details
11.10.2 Bio-Techne Business Overview
11.10.3 Bio-Techne Circulating Tumor Cells (CTC) Introduction
11.10.4 Bio-Techne Revenue in Circulating Tumor Cells (CTC) Business (2020-2025)
11.10.5 Bio-Techne Recent Development
11.11 BioFluidica
11.11.1 BioFluidica Company Details
11.11.2 BioFluidica Business Overview
11.11.3 BioFluidica Circulating Tumor Cells (CTC) Introduction
11.11.4 BioFluidica Revenue in Circulating Tumor Cells (CTC) Business (2020-2025)
11.11.5 BioFluidica Recent Development
11.12 Gilupi
11.12.1 Gilupi Company Details
11.12.2 Gilupi Business Overview
11.12.3 Gilupi Circulating Tumor Cells (CTC) Introduction
11.12.4 Gilupi Revenue in Circulating Tumor Cells (CTC) Business (2020-2025)
11.12.5 Gilupi Recent Development
11.13 BioView
11.13.1 BioView Company Details
11.13.2 BioView Business Overview
11.13.3 BioView Circulating Tumor Cells (CTC) Introduction
11.13.4 BioView Revenue in Circulating Tumor Cells (CTC) Business (2020-2025)
11.13.5 BioView Recent Development
11.14 ScreenCell
11.14.1 ScreenCell Company Details
11.14.2 ScreenCell Business Overview
11.14.3 ScreenCell Circulating Tumor Cells (CTC) Introduction
11.14.4 ScreenCell Revenue in Circulating Tumor Cells (CTC) Business (2020-2025)
11.14.5 ScreenCell Recent Development
11.15 Wuhan YZY Medical Science & Technology
11.15.1 Wuhan YZY Medical Science & Technology Company Details
11.15.2 Wuhan YZY Medical Science & Technology Business Overview
11.15.3 Wuhan YZY Medical Science & Technology Circulating Tumor Cells (CTC) Introduction
11.15.4 Wuhan YZY Medical Science & Technology Revenue in Circulating Tumor Cells (CTC) Business (2020-2025)
11.15.5 Wuhan YZY Medical Science & Technology Recent Development
11.16 NanoLite Systems
11.16.1 NanoLite Systems Company Details
11.16.2 NanoLite Systems Business Overview
11.16.3 NanoLite Systems Circulating Tumor Cells (CTC) Introduction
11.16.4 NanoLite Systems Revenue in Circulating Tumor Cells (CTC) Business (2020-2025)
11.16.5 NanoLite Systems Recent Development
11.17 Watson Biotech
11.17.1 Watson Biotech Company Details
11.17.2 Watson Biotech Business Overview
11.17.3 Watson Biotech Circulating Tumor Cells (CTC) Introduction
11.17.4 Watson Biotech Revenue in Circulating Tumor Cells (CTC) Business (2020-2025)
11.17.5 Watson Biotech Recent Development
11.18 DunWill
11.18.1 DunWill Company Details
11.18.2 DunWill Business Overview
11.18.3 DunWill Circulating Tumor Cells (CTC) Introduction
11.18.4 DunWill Revenue in Circulating Tumor Cells (CTC) Business (2020-2025)
11.18.5 DunWill Recent Development
11.19 Guangzhou Wondfo Biotech
11.19.1 Guangzhou Wondfo Biotech Company Details
11.19.2 Guangzhou Wondfo Biotech Business Overview
11.19.3 Guangzhou Wondfo Biotech Circulating Tumor Cells (CTC) Introduction
11.19.4 Guangzhou Wondfo Biotech Revenue in Circulating Tumor Cells (CTC) Business (2020-2025)
11.19.5 Guangzhou Wondfo Biotech Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Circulating Tumor Cells (CTC) Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Testing Equipment and Instruments
1.2.3 Kits and Reagents
1.2.4 Blood Collection Tubes
1.2.5 Others
1.3 Market by Application
1.3.1 Global Circulating Tumor Cells (CTC) Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Clinical Diagnosis and Treatment
1.3.3 Screening and Monitoring
1.3.4 Drug/Therapy Development
1.3.5 Tumor Pathology Research
1.3.6 Emt Biomarker Research
1.3.7 Cancer Stem Cell Research
1.3.8 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Circulating Tumor Cells (CTC) Market Perspective (2020-2031)
2.2 Global Circulating Tumor Cells (CTC) Growth Trends by Region
2.2.1 Global Circulating Tumor Cells (CTC) Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Circulating Tumor Cells (CTC) Historic Market Size by Region (2020-2025)
2.2.3 Circulating Tumor Cells (CTC) Forecasted Market Size by Region (2026-2031)
2.3 Circulating Tumor Cells (CTC) Market Dynamics
2.3.1 Circulating Tumor Cells (CTC) Industry Trends
2.3.2 Circulating Tumor Cells (CTC) Market Drivers
2.3.3 Circulating Tumor Cells (CTC) Market Challenges
2.3.4 Circulating Tumor Cells (CTC) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Circulating Tumor Cells (CTC) Players by Revenue
3.1.1 Global Top Circulating Tumor Cells (CTC) Players by Revenue (2020-2025)
3.1.2 Global Circulating Tumor Cells (CTC) Revenue Market Share by Players (2020-2025)
3.2 Global Top Circulating Tumor Cells (CTC) Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Circulating Tumor Cells (CTC) Revenue
3.4 Global Circulating Tumor Cells (CTC) Market Concentration Ratio
3.4.1 Global Circulating Tumor Cells (CTC) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Circulating Tumor Cells (CTC) Revenue in 2024
3.5 Global Key Players of Circulating Tumor Cells (CTC) Head office and Area Served
3.6 Global Key Players of Circulating Tumor Cells (CTC), Product and Application
3.7 Global Key Players of Circulating Tumor Cells (CTC), Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Circulating Tumor Cells (CTC) Breakdown Data by Type
4.1 Global Circulating Tumor Cells (CTC) Historic Market Size by Type (2020-2025)
4.2 Global Circulating Tumor Cells (CTC) Forecasted Market Size by Type (2026-2031)
5 Circulating Tumor Cells (CTC) Breakdown Data by Application
5.1 Global Circulating Tumor Cells (CTC) Historic Market Size by Application (2020-2025)
5.2 Global Circulating Tumor Cells (CTC) Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Circulating Tumor Cells (CTC) Market Size (2020-2031)
6.2 North America Circulating Tumor Cells (CTC) Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Circulating Tumor Cells (CTC) Market Size by Country (2020-2025)
6.4 North America Circulating Tumor Cells (CTC) Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Circulating Tumor Cells (CTC) Market Size (2020-2031)
7.2 Europe Circulating Tumor Cells (CTC) Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Circulating Tumor Cells (CTC) Market Size by Country (2020-2025)
7.4 Europe Circulating Tumor Cells (CTC) Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Circulating Tumor Cells (CTC) Market Size (2020-2031)
8.2 Asia-Pacific Circulating Tumor Cells (CTC) Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Circulating Tumor Cells (CTC) Market Size by Region (2020-2025)
8.4 Asia-Pacific Circulating Tumor Cells (CTC) Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Circulating Tumor Cells (CTC) Market Size (2020-2031)
9.2 Latin America Circulating Tumor Cells (CTC) Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Circulating Tumor Cells (CTC) Market Size by Country (2020-2025)
9.4 Latin America Circulating Tumor Cells (CTC) Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Circulating Tumor Cells (CTC) Market Size (2020-2031)
10.2 Middle East & Africa Circulating Tumor Cells (CTC) Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Circulating Tumor Cells (CTC) Market Size by Country (2020-2025)
10.4 Middle East & Africa Circulating Tumor Cells (CTC) Market Size by Country (2026-2031)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Qiagen
11.1.1 Qiagen Company Details
11.1.2 Qiagen Business Overview
11.1.3 Qiagen Circulating Tumor Cells (CTC) Introduction
11.1.4 Qiagen Revenue in Circulating Tumor Cells (CTC) Business (2020-2025)
11.1.5 Qiagen Recent Development
11.2 Bio-Rad
11.2.1 Bio-Rad Company Details
11.2.2 Bio-Rad Business Overview
11.2.3 Bio-Rad Circulating Tumor Cells (CTC) Introduction
11.2.4 Bio-Rad Revenue in Circulating Tumor Cells (CTC) Business (2020-2025)
11.2.5 Bio-Rad Recent Development
11.3 Johnson & Johnson
11.3.1 Johnson & Johnson Company Details
11.3.2 Johnson & Johnson Business Overview
11.3.3 Johnson & Johnson Circulating Tumor Cells (CTC) Introduction
11.3.4 Johnson & Johnson Revenue in Circulating Tumor Cells (CTC) Business (2020-2025)
11.3.5 Johnson & Johnson Recent Development
11.4 Thermo Fisher Scientific
11.4.1 Thermo Fisher Scientific Company Details
11.4.2 Thermo Fisher Scientific Business Overview
11.4.3 Thermo Fisher Scientific Circulating Tumor Cells (CTC) Introduction
11.4.4 Thermo Fisher Scientific Revenue in Circulating Tumor Cells (CTC) Business (2020-2025)
11.4.5 Thermo Fisher Scientific Recent Development
11.5 Ikonisys
11.5.1 Ikonisys Company Details
11.5.2 Ikonisys Business Overview
11.5.3 Ikonisys Circulating Tumor Cells (CTC) Introduction
11.5.4 Ikonisys Revenue in Circulating Tumor Cells (CTC) Business (2020-2025)
11.5.5 Ikonisys Recent Development
11.6 Miltenyi Biotech
11.6.1 Miltenyi Biotech Company Details
11.6.2 Miltenyi Biotech Business Overview
11.6.3 Miltenyi Biotech Circulating Tumor Cells (CTC) Introduction
11.6.4 Miltenyi Biotech Revenue in Circulating Tumor Cells (CTC) Business (2020-2025)
11.6.5 Miltenyi Biotech Recent Development
11.7 Rarecells
11.7.1 Rarecells Company Details
11.7.2 Rarecells Business Overview
11.7.3 Rarecells Circulating Tumor Cells (CTC) Introduction
11.7.4 Rarecells Revenue in Circulating Tumor Cells (CTC) Business (2020-2025)
11.7.5 Rarecells Recent Development
11.8 Vitatex
11.8.1 Vitatex Company Details
11.8.2 Vitatex Business Overview
11.8.3 Vitatex Circulating Tumor Cells (CTC) Introduction
11.8.4 Vitatex Revenue in Circulating Tumor Cells (CTC) Business (2020-2025)
11.8.5 Vitatex Recent Development
11.9 Menarini Silicon Biosystems
11.9.1 Menarini Silicon Biosystems Company Details
11.9.2 Menarini Silicon Biosystems Business Overview
11.9.3 Menarini Silicon Biosystems Circulating Tumor Cells (CTC) Introduction
11.9.4 Menarini Silicon Biosystems Revenue in Circulating Tumor Cells (CTC) Business (2020-2025)
11.9.5 Menarini Silicon Biosystems Recent Development
11.10 Bio-Techne
11.10.1 Bio-Techne Company Details
11.10.2 Bio-Techne Business Overview
11.10.3 Bio-Techne Circulating Tumor Cells (CTC) Introduction
11.10.4 Bio-Techne Revenue in Circulating Tumor Cells (CTC) Business (2020-2025)
11.10.5 Bio-Techne Recent Development
11.11 BioFluidica
11.11.1 BioFluidica Company Details
11.11.2 BioFluidica Business Overview
11.11.3 BioFluidica Circulating Tumor Cells (CTC) Introduction
11.11.4 BioFluidica Revenue in Circulating Tumor Cells (CTC) Business (2020-2025)
11.11.5 BioFluidica Recent Development
11.12 Gilupi
11.12.1 Gilupi Company Details
11.12.2 Gilupi Business Overview
11.12.3 Gilupi Circulating Tumor Cells (CTC) Introduction
11.12.4 Gilupi Revenue in Circulating Tumor Cells (CTC) Business (2020-2025)
11.12.5 Gilupi Recent Development
11.13 BioView
11.13.1 BioView Company Details
11.13.2 BioView Business Overview
11.13.3 BioView Circulating Tumor Cells (CTC) Introduction
11.13.4 BioView Revenue in Circulating Tumor Cells (CTC) Business (2020-2025)
11.13.5 BioView Recent Development
11.14 ScreenCell
11.14.1 ScreenCell Company Details
11.14.2 ScreenCell Business Overview
11.14.3 ScreenCell Circulating Tumor Cells (CTC) Introduction
11.14.4 ScreenCell Revenue in Circulating Tumor Cells (CTC) Business (2020-2025)
11.14.5 ScreenCell Recent Development
11.15 Wuhan YZY Medical Science & Technology
11.15.1 Wuhan YZY Medical Science & Technology Company Details
11.15.2 Wuhan YZY Medical Science & Technology Business Overview
11.15.3 Wuhan YZY Medical Science & Technology Circulating Tumor Cells (CTC) Introduction
11.15.4 Wuhan YZY Medical Science & Technology Revenue in Circulating Tumor Cells (CTC) Business (2020-2025)
11.15.5 Wuhan YZY Medical Science & Technology Recent Development
11.16 NanoLite Systems
11.16.1 NanoLite Systems Company Details
11.16.2 NanoLite Systems Business Overview
11.16.3 NanoLite Systems Circulating Tumor Cells (CTC) Introduction
11.16.4 NanoLite Systems Revenue in Circulating Tumor Cells (CTC) Business (2020-2025)
11.16.5 NanoLite Systems Recent Development
11.17 Watson Biotech
11.17.1 Watson Biotech Company Details
11.17.2 Watson Biotech Business Overview
11.17.3 Watson Biotech Circulating Tumor Cells (CTC) Introduction
11.17.4 Watson Biotech Revenue in Circulating Tumor Cells (CTC) Business (2020-2025)
11.17.5 Watson Biotech Recent Development
11.18 DunWill
11.18.1 DunWill Company Details
11.18.2 DunWill Business Overview
11.18.3 DunWill Circulating Tumor Cells (CTC) Introduction
11.18.4 DunWill Revenue in Circulating Tumor Cells (CTC) Business (2020-2025)
11.18.5 DunWill Recent Development
11.19 Guangzhou Wondfo Biotech
11.19.1 Guangzhou Wondfo Biotech Company Details
11.19.2 Guangzhou Wondfo Biotech Business Overview
11.19.3 Guangzhou Wondfo Biotech Circulating Tumor Cells (CTC) Introduction
11.19.4 Guangzhou Wondfo Biotech Revenue in Circulating Tumor Cells (CTC) Business (2020-2025)
11.19.5 Guangzhou Wondfo Biotech Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Circulating Tumor Cells (CTC) Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Testing Equipment and Instruments
Table 3. Key Players of Kits and Reagents
Table 4. Key Players of Blood Collection Tubes
Table 5. Key Players of Others
Table 6. Global Circulating Tumor Cells (CTC) Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Circulating Tumor Cells (CTC) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Circulating Tumor Cells (CTC) Market Size by Region (2020-2025) & (US$ Million)
Table 9. Global Circulating Tumor Cells (CTC) Market Share by Region (2020-2025)
Table 10. Global Circulating Tumor Cells (CTC) Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 11. Global Circulating Tumor Cells (CTC) Market Share by Region (2026-2031)
Table 12. Circulating Tumor Cells (CTC) Market Trends
Table 13. Circulating Tumor Cells (CTC) Market Drivers
Table 14. Circulating Tumor Cells (CTC) Market Challenges
Table 15. Circulating Tumor Cells (CTC) Market Restraints
Table 16. Global Circulating Tumor Cells (CTC) Revenue by Players (2020-2025) & (US$ Million)
Table 17. Global Circulating Tumor Cells (CTC) Market Share by Players (2020-2025)
Table 18. Global Top Circulating Tumor Cells (CTC) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Circulating Tumor Cells (CTC) as of 2024)
Table 19. Ranking of Global Top Circulating Tumor Cells (CTC) Companies by Revenue (US$ Million) in 2024
Table 20. Global 5 Largest Players Market Share by Circulating Tumor Cells (CTC) Revenue (CR5 and HHI) & (2020-2025)
Table 21. Global Key Players of Circulating Tumor Cells (CTC), Headquarters and Area Served
Table 22. Global Key Players of Circulating Tumor Cells (CTC), Product and Application
Table 23. Global Key Players of Circulating Tumor Cells (CTC), Date of Enter into This Industry
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Circulating Tumor Cells (CTC) Market Size by Type (2020-2025) & (US$ Million)
Table 26. Global Circulating Tumor Cells (CTC) Revenue Market Share by Type (2020-2025)
Table 27. Global Circulating Tumor Cells (CTC) Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 28. Global Circulating Tumor Cells (CTC) Revenue Market Share by Type (2026-2031)
Table 29. Global Circulating Tumor Cells (CTC) Market Size by Application (2020-2025) & (US$ Million)
Table 30. Global Circulating Tumor Cells (CTC) Revenue Market Share by Application (2020-2025)
Table 31. Global Circulating Tumor Cells (CTC) Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 32. Global Circulating Tumor Cells (CTC) Revenue Market Share by Application (2026-2031)
Table 33. North America Circulating Tumor Cells (CTC) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 34. North America Circulating Tumor Cells (CTC) Market Size by Country (2020-2025) & (US$ Million)
Table 35. North America Circulating Tumor Cells (CTC) Market Size by Country (2026-2031) & (US$ Million)
Table 36. Europe Circulating Tumor Cells (CTC) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. Europe Circulating Tumor Cells (CTC) Market Size by Country (2020-2025) & (US$ Million)
Table 38. Europe Circulating Tumor Cells (CTC) Market Size by Country (2026-2031) & (US$ Million)
Table 39. Asia-Pacific Circulating Tumor Cells (CTC) Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 40. Asia-Pacific Circulating Tumor Cells (CTC) Market Size by Region (2020-2025) & (US$ Million)
Table 41. Asia-Pacific Circulating Tumor Cells (CTC) Market Size by Region (2026-2031) & (US$ Million)
Table 42. Latin America Circulating Tumor Cells (CTC) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 43. Latin America Circulating Tumor Cells (CTC) Market Size by Country (2020-2025) & (US$ Million)
Table 44. Latin America Circulating Tumor Cells (CTC) Market Size by Country (2026-2031) & (US$ Million)
Table 45. Middle East & Africa Circulating Tumor Cells (CTC) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Middle East & Africa Circulating Tumor Cells (CTC) Market Size by Country (2020-2025) & (US$ Million)
Table 47. Middle East & Africa Circulating Tumor Cells (CTC) Market Size by Country (2026-2031) & (US$ Million)
Table 48. Qiagen Company Details
Table 49. Qiagen Business Overview
Table 50. Qiagen Circulating Tumor Cells (CTC) Product
Table 51. Qiagen Revenue in Circulating Tumor Cells (CTC) Business (2020-2025) & (US$ Million)
Table 52. Qiagen Recent Development
Table 53. Bio-Rad Company Details
Table 54. Bio-Rad Business Overview
Table 55. Bio-Rad Circulating Tumor Cells (CTC) Product
Table 56. Bio-Rad Revenue in Circulating Tumor Cells (CTC) Business (2020-2025) & (US$ Million)
Table 57. Bio-Rad Recent Development
Table 58. Johnson & Johnson Company Details
Table 59. Johnson & Johnson Business Overview
Table 60. Johnson & Johnson Circulating Tumor Cells (CTC) Product
Table 61. Johnson & Johnson Revenue in Circulating Tumor Cells (CTC) Business (2020-2025) & (US$ Million)
Table 62. Johnson & Johnson Recent Development
Table 63. Thermo Fisher Scientific Company Details
Table 64. Thermo Fisher Scientific Business Overview
Table 65. Thermo Fisher Scientific Circulating Tumor Cells (CTC) Product
Table 66. Thermo Fisher Scientific Revenue in Circulating Tumor Cells (CTC) Business (2020-2025) & (US$ Million)
Table 67. Thermo Fisher Scientific Recent Development
Table 68. Ikonisys Company Details
Table 69. Ikonisys Business Overview
Table 70. Ikonisys Circulating Tumor Cells (CTC) Product
Table 71. Ikonisys Revenue in Circulating Tumor Cells (CTC) Business (2020-2025) & (US$ Million)
Table 72. Ikonisys Recent Development
Table 73. Miltenyi Biotech Company Details
Table 74. Miltenyi Biotech Business Overview
Table 75. Miltenyi Biotech Circulating Tumor Cells (CTC) Product
Table 76. Miltenyi Biotech Revenue in Circulating Tumor Cells (CTC) Business (2020-2025) & (US$ Million)
Table 77. Miltenyi Biotech Recent Development
Table 78. Rarecells Company Details
Table 79. Rarecells Business Overview
Table 80. Rarecells Circulating Tumor Cells (CTC) Product
Table 81. Rarecells Revenue in Circulating Tumor Cells (CTC) Business (2020-2025) & (US$ Million)
Table 82. Rarecells Recent Development
Table 83. Vitatex Company Details
Table 84. Vitatex Business Overview
Table 85. Vitatex Circulating Tumor Cells (CTC) Product
Table 86. Vitatex Revenue in Circulating Tumor Cells (CTC) Business (2020-2025) & (US$ Million)
Table 87. Vitatex Recent Development
Table 88. Menarini Silicon Biosystems Company Details
Table 89. Menarini Silicon Biosystems Business Overview
Table 90. Menarini Silicon Biosystems Circulating Tumor Cells (CTC) Product
Table 91. Menarini Silicon Biosystems Revenue in Circulating Tumor Cells (CTC) Business (2020-2025) & (US$ Million)
Table 92. Menarini Silicon Biosystems Recent Development
Table 93. Bio-Techne Company Details
Table 94. Bio-Techne Business Overview
Table 95. Bio-Techne Circulating Tumor Cells (CTC) Product
Table 96. Bio-Techne Revenue in Circulating Tumor Cells (CTC) Business (2020-2025) & (US$ Million)
Table 97. Bio-Techne Recent Development
Table 98. BioFluidica Company Details
Table 99. BioFluidica Business Overview
Table 100. BioFluidica Circulating Tumor Cells (CTC) Product
Table 101. BioFluidica Revenue in Circulating Tumor Cells (CTC) Business (2020-2025) & (US$ Million)
Table 102. BioFluidica Recent Development
Table 103. Gilupi Company Details
Table 104. Gilupi Business Overview
Table 105. Gilupi Circulating Tumor Cells (CTC) Product
Table 106. Gilupi Revenue in Circulating Tumor Cells (CTC) Business (2020-2025) & (US$ Million)
Table 107. Gilupi Recent Development
Table 108. BioView Company Details
Table 109. BioView Business Overview
Table 110. BioView Circulating Tumor Cells (CTC) Product
Table 111. BioView Revenue in Circulating Tumor Cells (CTC) Business (2020-2025) & (US$ Million)
Table 112. BioView Recent Development
Table 113. ScreenCell Company Details
Table 114. ScreenCell Business Overview
Table 115. ScreenCell Circulating Tumor Cells (CTC) Product
Table 116. ScreenCell Revenue in Circulating Tumor Cells (CTC) Business (2020-2025) & (US$ Million)
Table 117. ScreenCell Recent Development
Table 118. Wuhan YZY Medical Science & Technology Company Details
Table 119. Wuhan YZY Medical Science & Technology Business Overview
Table 120. Wuhan YZY Medical Science & Technology Circulating Tumor Cells (CTC) Product
Table 121. Wuhan YZY Medical Science & Technology Revenue in Circulating Tumor Cells (CTC) Business (2020-2025) & (US$ Million)
Table 122. Wuhan YZY Medical Science & Technology Recent Development
Table 123. NanoLite Systems Company Details
Table 124. NanoLite Systems Business Overview
Table 125. NanoLite Systems Circulating Tumor Cells (CTC) Product
Table 126. NanoLite Systems Revenue in Circulating Tumor Cells (CTC) Business (2020-2025) & (US$ Million)
Table 127. NanoLite Systems Recent Development
Table 128. Watson Biotech Company Details
Table 129. Watson Biotech Business Overview
Table 130. Watson Biotech Circulating Tumor Cells (CTC) Product
Table 131. Watson Biotech Revenue in Circulating Tumor Cells (CTC) Business (2020-2025) & (US$ Million)
Table 132. Watson Biotech Recent Development
Table 133. DunWill Company Details
Table 134. DunWill Business Overview
Table 135. DunWill Circulating Tumor Cells (CTC) Product
Table 136. DunWill Revenue in Circulating Tumor Cells (CTC) Business (2020-2025) & (US$ Million)
Table 137. DunWill Recent Development
Table 138. Guangzhou Wondfo Biotech Company Details
Table 139. Guangzhou Wondfo Biotech Business Overview
Table 140. Guangzhou Wondfo Biotech Circulating Tumor Cells (CTC) Product
Table 141. Guangzhou Wondfo Biotech Revenue in Circulating Tumor Cells (CTC) Business (2020-2025) & (US$ Million)
Table 142. Guangzhou Wondfo Biotech Recent Development
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
Table 146. Authors List of This Report
List of Figures
Figure 1. Circulating Tumor Cells (CTC) Picture
Figure 2. Global Circulating Tumor Cells (CTC) Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Circulating Tumor Cells (CTC) Market Share by Type: 2024 VS 2031
Figure 4. Testing Equipment and Instruments Features
Figure 5. Kits and Reagents Features
Figure 6. Blood Collection Tubes Features
Figure 7. Others Features
Figure 8. Global Circulating Tumor Cells (CTC) Market Size by Application (2020-2031) & (US$ Million)
Figure 9. Global Circulating Tumor Cells (CTC) Market Share by Application: 2024 VS 2031
Figure 10. Clinical Diagnosis and Treatment Case Studies
Figure 11. Screening and Monitoring Case Studies
Figure 12. Drug/Therapy Development Case Studies
Figure 13. Tumor Pathology Research Case Studies
Figure 14. Emt Biomarker Research Case Studies
Figure 15. Cancer Stem Cell Research Case Studies
Figure 16. Others Case Studies
Figure 17. Circulating Tumor Cells (CTC) Report Years Considered
Figure 18. Global Circulating Tumor Cells (CTC) Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 19. Global Circulating Tumor Cells (CTC) Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 20. Global Circulating Tumor Cells (CTC) Market Share by Region: 2024 VS 2031
Figure 21. Global Circulating Tumor Cells (CTC) Market Share by Players in 2024
Figure 22. Global Circulating Tumor Cells (CTC) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 23. The Top 10 and 5 Players Market Share by Circulating Tumor Cells (CTC) Revenue in 2024
Figure 24. North America Circulating Tumor Cells (CTC) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. North America Circulating Tumor Cells (CTC) Market Share by Country (2020-2031)
Figure 26. United States Circulating Tumor Cells (CTC) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Canada Circulating Tumor Cells (CTC) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Europe Circulating Tumor Cells (CTC) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Europe Circulating Tumor Cells (CTC) Market Share by Country (2020-2031)
Figure 30. Germany Circulating Tumor Cells (CTC) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. France Circulating Tumor Cells (CTC) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. U.K. Circulating Tumor Cells (CTC) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Italy Circulating Tumor Cells (CTC) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Russia Circulating Tumor Cells (CTC) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Ireland Circulating Tumor Cells (CTC) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Asia-Pacific Circulating Tumor Cells (CTC) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Asia-Pacific Circulating Tumor Cells (CTC) Market Share by Region (2020-2031)
Figure 38. China Circulating Tumor Cells (CTC) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Japan Circulating Tumor Cells (CTC) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. South Korea Circulating Tumor Cells (CTC) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Southeast Asia Circulating Tumor Cells (CTC) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. India Circulating Tumor Cells (CTC) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Australia & New Zealand Circulating Tumor Cells (CTC) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Latin America Circulating Tumor Cells (CTC) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Latin America Circulating Tumor Cells (CTC) Market Share by Country (2020-2031)
Figure 46. Mexico Circulating Tumor Cells (CTC) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Brazil Circulating Tumor Cells (CTC) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Middle East & Africa Circulating Tumor Cells (CTC) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Middle East & Africa Circulating Tumor Cells (CTC) Market Share by Country (2020-2031)
Figure 50. Israel Circulating Tumor Cells (CTC) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 51. Saudi Arabia Circulating Tumor Cells (CTC) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 52. UAE Circulating Tumor Cells (CTC) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 53. Qiagen Revenue Growth Rate in Circulating Tumor Cells (CTC) Business (2020-2025)
Figure 54. Bio-Rad Revenue Growth Rate in Circulating Tumor Cells (CTC) Business (2020-2025)
Figure 55. Johnson & Johnson Revenue Growth Rate in Circulating Tumor Cells (CTC) Business (2020-2025)
Figure 56. Thermo Fisher Scientific Revenue Growth Rate in Circulating Tumor Cells (CTC) Business (2020-2025)
Figure 57. Ikonisys Revenue Growth Rate in Circulating Tumor Cells (CTC) Business (2020-2025)
Figure 58. Miltenyi Biotech Revenue Growth Rate in Circulating Tumor Cells (CTC) Business (2020-2025)
Figure 59. Rarecells Revenue Growth Rate in Circulating Tumor Cells (CTC) Business (2020-2025)
Figure 60. Vitatex Revenue Growth Rate in Circulating Tumor Cells (CTC) Business (2020-2025)
Figure 61. Menarini Silicon Biosystems Revenue Growth Rate in Circulating Tumor Cells (CTC) Business (2020-2025)
Figure 62. Bio-Techne Revenue Growth Rate in Circulating Tumor Cells (CTC) Business (2020-2025)
Figure 63. BioFluidica Revenue Growth Rate in Circulating Tumor Cells (CTC) Business (2020-2025)
Figure 64. Gilupi Revenue Growth Rate in Circulating Tumor Cells (CTC) Business (2020-2025)
Figure 65. BioView Revenue Growth Rate in Circulating Tumor Cells (CTC) Business (2020-2025)
Figure 66. ScreenCell Revenue Growth Rate in Circulating Tumor Cells (CTC) Business (2020-2025)
Figure 67. Wuhan YZY Medical Science & Technology Revenue Growth Rate in Circulating Tumor Cells (CTC) Business (2020-2025)
Figure 68. NanoLite Systems Revenue Growth Rate in Circulating Tumor Cells (CTC) Business (2020-2025)
Figure 69. Watson Biotech Revenue Growth Rate in Circulating Tumor Cells (CTC) Business (2020-2025)
Figure 70. DunWill Revenue Growth Rate in Circulating Tumor Cells (CTC) Business (2020-2025)
Figure 71. Guangzhou Wondfo Biotech Revenue Growth Rate in Circulating Tumor Cells (CTC) Business (2020-2025)
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Figure 74. Key Executives Interviewed
Table 1. Global Circulating Tumor Cells (CTC) Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Testing Equipment and Instruments
Table 3. Key Players of Kits and Reagents
Table 4. Key Players of Blood Collection Tubes
Table 5. Key Players of Others
Table 6. Global Circulating Tumor Cells (CTC) Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Circulating Tumor Cells (CTC) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Circulating Tumor Cells (CTC) Market Size by Region (2020-2025) & (US$ Million)
Table 9. Global Circulating Tumor Cells (CTC) Market Share by Region (2020-2025)
Table 10. Global Circulating Tumor Cells (CTC) Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 11. Global Circulating Tumor Cells (CTC) Market Share by Region (2026-2031)
Table 12. Circulating Tumor Cells (CTC) Market Trends
Table 13. Circulating Tumor Cells (CTC) Market Drivers
Table 14. Circulating Tumor Cells (CTC) Market Challenges
Table 15. Circulating Tumor Cells (CTC) Market Restraints
Table 16. Global Circulating Tumor Cells (CTC) Revenue by Players (2020-2025) & (US$ Million)
Table 17. Global Circulating Tumor Cells (CTC) Market Share by Players (2020-2025)
Table 18. Global Top Circulating Tumor Cells (CTC) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Circulating Tumor Cells (CTC) as of 2024)
Table 19. Ranking of Global Top Circulating Tumor Cells (CTC) Companies by Revenue (US$ Million) in 2024
Table 20. Global 5 Largest Players Market Share by Circulating Tumor Cells (CTC) Revenue (CR5 and HHI) & (2020-2025)
Table 21. Global Key Players of Circulating Tumor Cells (CTC), Headquarters and Area Served
Table 22. Global Key Players of Circulating Tumor Cells (CTC), Product and Application
Table 23. Global Key Players of Circulating Tumor Cells (CTC), Date of Enter into This Industry
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Circulating Tumor Cells (CTC) Market Size by Type (2020-2025) & (US$ Million)
Table 26. Global Circulating Tumor Cells (CTC) Revenue Market Share by Type (2020-2025)
Table 27. Global Circulating Tumor Cells (CTC) Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 28. Global Circulating Tumor Cells (CTC) Revenue Market Share by Type (2026-2031)
Table 29. Global Circulating Tumor Cells (CTC) Market Size by Application (2020-2025) & (US$ Million)
Table 30. Global Circulating Tumor Cells (CTC) Revenue Market Share by Application (2020-2025)
Table 31. Global Circulating Tumor Cells (CTC) Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 32. Global Circulating Tumor Cells (CTC) Revenue Market Share by Application (2026-2031)
Table 33. North America Circulating Tumor Cells (CTC) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 34. North America Circulating Tumor Cells (CTC) Market Size by Country (2020-2025) & (US$ Million)
Table 35. North America Circulating Tumor Cells (CTC) Market Size by Country (2026-2031) & (US$ Million)
Table 36. Europe Circulating Tumor Cells (CTC) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. Europe Circulating Tumor Cells (CTC) Market Size by Country (2020-2025) & (US$ Million)
Table 38. Europe Circulating Tumor Cells (CTC) Market Size by Country (2026-2031) & (US$ Million)
Table 39. Asia-Pacific Circulating Tumor Cells (CTC) Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 40. Asia-Pacific Circulating Tumor Cells (CTC) Market Size by Region (2020-2025) & (US$ Million)
Table 41. Asia-Pacific Circulating Tumor Cells (CTC) Market Size by Region (2026-2031) & (US$ Million)
Table 42. Latin America Circulating Tumor Cells (CTC) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 43. Latin America Circulating Tumor Cells (CTC) Market Size by Country (2020-2025) & (US$ Million)
Table 44. Latin America Circulating Tumor Cells (CTC) Market Size by Country (2026-2031) & (US$ Million)
Table 45. Middle East & Africa Circulating Tumor Cells (CTC) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Middle East & Africa Circulating Tumor Cells (CTC) Market Size by Country (2020-2025) & (US$ Million)
Table 47. Middle East & Africa Circulating Tumor Cells (CTC) Market Size by Country (2026-2031) & (US$ Million)
Table 48. Qiagen Company Details
Table 49. Qiagen Business Overview
Table 50. Qiagen Circulating Tumor Cells (CTC) Product
Table 51. Qiagen Revenue in Circulating Tumor Cells (CTC) Business (2020-2025) & (US$ Million)
Table 52. Qiagen Recent Development
Table 53. Bio-Rad Company Details
Table 54. Bio-Rad Business Overview
Table 55. Bio-Rad Circulating Tumor Cells (CTC) Product
Table 56. Bio-Rad Revenue in Circulating Tumor Cells (CTC) Business (2020-2025) & (US$ Million)
Table 57. Bio-Rad Recent Development
Table 58. Johnson & Johnson Company Details
Table 59. Johnson & Johnson Business Overview
Table 60. Johnson & Johnson Circulating Tumor Cells (CTC) Product
Table 61. Johnson & Johnson Revenue in Circulating Tumor Cells (CTC) Business (2020-2025) & (US$ Million)
Table 62. Johnson & Johnson Recent Development
Table 63. Thermo Fisher Scientific Company Details
Table 64. Thermo Fisher Scientific Business Overview
Table 65. Thermo Fisher Scientific Circulating Tumor Cells (CTC) Product
Table 66. Thermo Fisher Scientific Revenue in Circulating Tumor Cells (CTC) Business (2020-2025) & (US$ Million)
Table 67. Thermo Fisher Scientific Recent Development
Table 68. Ikonisys Company Details
Table 69. Ikonisys Business Overview
Table 70. Ikonisys Circulating Tumor Cells (CTC) Product
Table 71. Ikonisys Revenue in Circulating Tumor Cells (CTC) Business (2020-2025) & (US$ Million)
Table 72. Ikonisys Recent Development
Table 73. Miltenyi Biotech Company Details
Table 74. Miltenyi Biotech Business Overview
Table 75. Miltenyi Biotech Circulating Tumor Cells (CTC) Product
Table 76. Miltenyi Biotech Revenue in Circulating Tumor Cells (CTC) Business (2020-2025) & (US$ Million)
Table 77. Miltenyi Biotech Recent Development
Table 78. Rarecells Company Details
Table 79. Rarecells Business Overview
Table 80. Rarecells Circulating Tumor Cells (CTC) Product
Table 81. Rarecells Revenue in Circulating Tumor Cells (CTC) Business (2020-2025) & (US$ Million)
Table 82. Rarecells Recent Development
Table 83. Vitatex Company Details
Table 84. Vitatex Business Overview
Table 85. Vitatex Circulating Tumor Cells (CTC) Product
Table 86. Vitatex Revenue in Circulating Tumor Cells (CTC) Business (2020-2025) & (US$ Million)
Table 87. Vitatex Recent Development
Table 88. Menarini Silicon Biosystems Company Details
Table 89. Menarini Silicon Biosystems Business Overview
Table 90. Menarini Silicon Biosystems Circulating Tumor Cells (CTC) Product
Table 91. Menarini Silicon Biosystems Revenue in Circulating Tumor Cells (CTC) Business (2020-2025) & (US$ Million)
Table 92. Menarini Silicon Biosystems Recent Development
Table 93. Bio-Techne Company Details
Table 94. Bio-Techne Business Overview
Table 95. Bio-Techne Circulating Tumor Cells (CTC) Product
Table 96. Bio-Techne Revenue in Circulating Tumor Cells (CTC) Business (2020-2025) & (US$ Million)
Table 97. Bio-Techne Recent Development
Table 98. BioFluidica Company Details
Table 99. BioFluidica Business Overview
Table 100. BioFluidica Circulating Tumor Cells (CTC) Product
Table 101. BioFluidica Revenue in Circulating Tumor Cells (CTC) Business (2020-2025) & (US$ Million)
Table 102. BioFluidica Recent Development
Table 103. Gilupi Company Details
Table 104. Gilupi Business Overview
Table 105. Gilupi Circulating Tumor Cells (CTC) Product
Table 106. Gilupi Revenue in Circulating Tumor Cells (CTC) Business (2020-2025) & (US$ Million)
Table 107. Gilupi Recent Development
Table 108. BioView Company Details
Table 109. BioView Business Overview
Table 110. BioView Circulating Tumor Cells (CTC) Product
Table 111. BioView Revenue in Circulating Tumor Cells (CTC) Business (2020-2025) & (US$ Million)
Table 112. BioView Recent Development
Table 113. ScreenCell Company Details
Table 114. ScreenCell Business Overview
Table 115. ScreenCell Circulating Tumor Cells (CTC) Product
Table 116. ScreenCell Revenue in Circulating Tumor Cells (CTC) Business (2020-2025) & (US$ Million)
Table 117. ScreenCell Recent Development
Table 118. Wuhan YZY Medical Science & Technology Company Details
Table 119. Wuhan YZY Medical Science & Technology Business Overview
Table 120. Wuhan YZY Medical Science & Technology Circulating Tumor Cells (CTC) Product
Table 121. Wuhan YZY Medical Science & Technology Revenue in Circulating Tumor Cells (CTC) Business (2020-2025) & (US$ Million)
Table 122. Wuhan YZY Medical Science & Technology Recent Development
Table 123. NanoLite Systems Company Details
Table 124. NanoLite Systems Business Overview
Table 125. NanoLite Systems Circulating Tumor Cells (CTC) Product
Table 126. NanoLite Systems Revenue in Circulating Tumor Cells (CTC) Business (2020-2025) & (US$ Million)
Table 127. NanoLite Systems Recent Development
Table 128. Watson Biotech Company Details
Table 129. Watson Biotech Business Overview
Table 130. Watson Biotech Circulating Tumor Cells (CTC) Product
Table 131. Watson Biotech Revenue in Circulating Tumor Cells (CTC) Business (2020-2025) & (US$ Million)
Table 132. Watson Biotech Recent Development
Table 133. DunWill Company Details
Table 134. DunWill Business Overview
Table 135. DunWill Circulating Tumor Cells (CTC) Product
Table 136. DunWill Revenue in Circulating Tumor Cells (CTC) Business (2020-2025) & (US$ Million)
Table 137. DunWill Recent Development
Table 138. Guangzhou Wondfo Biotech Company Details
Table 139. Guangzhou Wondfo Biotech Business Overview
Table 140. Guangzhou Wondfo Biotech Circulating Tumor Cells (CTC) Product
Table 141. Guangzhou Wondfo Biotech Revenue in Circulating Tumor Cells (CTC) Business (2020-2025) & (US$ Million)
Table 142. Guangzhou Wondfo Biotech Recent Development
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
Table 146. Authors List of This Report
List of Figures
Figure 1. Circulating Tumor Cells (CTC) Picture
Figure 2. Global Circulating Tumor Cells (CTC) Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Circulating Tumor Cells (CTC) Market Share by Type: 2024 VS 2031
Figure 4. Testing Equipment and Instruments Features
Figure 5. Kits and Reagents Features
Figure 6. Blood Collection Tubes Features
Figure 7. Others Features
Figure 8. Global Circulating Tumor Cells (CTC) Market Size by Application (2020-2031) & (US$ Million)
Figure 9. Global Circulating Tumor Cells (CTC) Market Share by Application: 2024 VS 2031
Figure 10. Clinical Diagnosis and Treatment Case Studies
Figure 11. Screening and Monitoring Case Studies
Figure 12. Drug/Therapy Development Case Studies
Figure 13. Tumor Pathology Research Case Studies
Figure 14. Emt Biomarker Research Case Studies
Figure 15. Cancer Stem Cell Research Case Studies
Figure 16. Others Case Studies
Figure 17. Circulating Tumor Cells (CTC) Report Years Considered
Figure 18. Global Circulating Tumor Cells (CTC) Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 19. Global Circulating Tumor Cells (CTC) Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 20. Global Circulating Tumor Cells (CTC) Market Share by Region: 2024 VS 2031
Figure 21. Global Circulating Tumor Cells (CTC) Market Share by Players in 2024
Figure 22. Global Circulating Tumor Cells (CTC) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 23. The Top 10 and 5 Players Market Share by Circulating Tumor Cells (CTC) Revenue in 2024
Figure 24. North America Circulating Tumor Cells (CTC) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. North America Circulating Tumor Cells (CTC) Market Share by Country (2020-2031)
Figure 26. United States Circulating Tumor Cells (CTC) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Canada Circulating Tumor Cells (CTC) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Europe Circulating Tumor Cells (CTC) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Europe Circulating Tumor Cells (CTC) Market Share by Country (2020-2031)
Figure 30. Germany Circulating Tumor Cells (CTC) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. France Circulating Tumor Cells (CTC) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. U.K. Circulating Tumor Cells (CTC) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Italy Circulating Tumor Cells (CTC) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Russia Circulating Tumor Cells (CTC) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Ireland Circulating Tumor Cells (CTC) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Asia-Pacific Circulating Tumor Cells (CTC) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Asia-Pacific Circulating Tumor Cells (CTC) Market Share by Region (2020-2031)
Figure 38. China Circulating Tumor Cells (CTC) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Japan Circulating Tumor Cells (CTC) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. South Korea Circulating Tumor Cells (CTC) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Southeast Asia Circulating Tumor Cells (CTC) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. India Circulating Tumor Cells (CTC) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Australia & New Zealand Circulating Tumor Cells (CTC) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Latin America Circulating Tumor Cells (CTC) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Latin America Circulating Tumor Cells (CTC) Market Share by Country (2020-2031)
Figure 46. Mexico Circulating Tumor Cells (CTC) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Brazil Circulating Tumor Cells (CTC) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Middle East & Africa Circulating Tumor Cells (CTC) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Middle East & Africa Circulating Tumor Cells (CTC) Market Share by Country (2020-2031)
Figure 50. Israel Circulating Tumor Cells (CTC) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 51. Saudi Arabia Circulating Tumor Cells (CTC) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 52. UAE Circulating Tumor Cells (CTC) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 53. Qiagen Revenue Growth Rate in Circulating Tumor Cells (CTC) Business (2020-2025)
Figure 54. Bio-Rad Revenue Growth Rate in Circulating Tumor Cells (CTC) Business (2020-2025)
Figure 55. Johnson & Johnson Revenue Growth Rate in Circulating Tumor Cells (CTC) Business (2020-2025)
Figure 56. Thermo Fisher Scientific Revenue Growth Rate in Circulating Tumor Cells (CTC) Business (2020-2025)
Figure 57. Ikonisys Revenue Growth Rate in Circulating Tumor Cells (CTC) Business (2020-2025)
Figure 58. Miltenyi Biotech Revenue Growth Rate in Circulating Tumor Cells (CTC) Business (2020-2025)
Figure 59. Rarecells Revenue Growth Rate in Circulating Tumor Cells (CTC) Business (2020-2025)
Figure 60. Vitatex Revenue Growth Rate in Circulating Tumor Cells (CTC) Business (2020-2025)
Figure 61. Menarini Silicon Biosystems Revenue Growth Rate in Circulating Tumor Cells (CTC) Business (2020-2025)
Figure 62. Bio-Techne Revenue Growth Rate in Circulating Tumor Cells (CTC) Business (2020-2025)
Figure 63. BioFluidica Revenue Growth Rate in Circulating Tumor Cells (CTC) Business (2020-2025)
Figure 64. Gilupi Revenue Growth Rate in Circulating Tumor Cells (CTC) Business (2020-2025)
Figure 65. BioView Revenue Growth Rate in Circulating Tumor Cells (CTC) Business (2020-2025)
Figure 66. ScreenCell Revenue Growth Rate in Circulating Tumor Cells (CTC) Business (2020-2025)
Figure 67. Wuhan YZY Medical Science & Technology Revenue Growth Rate in Circulating Tumor Cells (CTC) Business (2020-2025)
Figure 68. NanoLite Systems Revenue Growth Rate in Circulating Tumor Cells (CTC) Business (2020-2025)
Figure 69. Watson Biotech Revenue Growth Rate in Circulating Tumor Cells (CTC) Business (2020-2025)
Figure 70. DunWill Revenue Growth Rate in Circulating Tumor Cells (CTC) Business (2020-2025)
Figure 71. Guangzhou Wondfo Biotech Revenue Growth Rate in Circulating Tumor Cells (CTC) Business (2020-2025)
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Figure 74. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global White Oil Market Research Report 2025
Aug 11, 25
Global Piezo Materials Market Research Report 2025
Aug 11, 25
Global Piezoceramic Materials Market Research Report 2025
Aug 11, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232